Patents by Inventor Britta Will

Britta Will has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERLEUKIN-8 FOR MAINTENANCE OF HUMAN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME AND USES THEREOF
    Publication number: 20210355501
    Abstract: Methods are disclosed for enhancing growth of a human acute myeloid leukemia (AML) sample, a human myelodysplastic syndrome (MDS) sample, a human IL-8 dependent tumor sample, human preleukemia cells, and a human preleukemia clone or subclone ex vivo or in a xenograft animal model comprising adding human interleukin-8 (hIL-8) or a hIL-8 agonist to the sample or administering hIL-8 or a hIL-8 agonist to the animal model or expressing a gene encoding hIL-8 or a hIL-8 agonist in the animal model. The invention also provides a transgenic animal that expresses a gene encoding human interleukin-8 (hIL-8) or a hIL-8 agonist, which can be used to test the effectiveness of treatments for AML, MDS and IL-8 dependent tumors.
    Type: Application
    Filed: September 23, 2019
    Publication date: November 18, 2021
    Inventors: Amit Verma, Ulrich Steidl, Britta Will, Tihomira Todorova
  • Treatment of acute myeloid leukemia and myelodysplastic syndromes
    Patent number: 9873918
    Abstract: Methods are disclosed for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes using interleukin 1 receptor accessory protein and other targets.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: January 23, 2018
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventors: Ulrich G. Steidl, Laura Barreyro De Pujato, Britta Will, Amit Verma
  • TARGETS FOR DIAGNOSIS, PROGNOSIS AND THERAPY OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    Publication number: 20150147271
    Abstract: Methods are disclosed for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes using interleukin 1 receptor accessory protein and other targets.
    Type: Application
    Filed: August 9, 2012
    Publication date: May 28, 2015
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Ulrich G. Steidl, Laura Barreyro De Pujato, Britta Will